Octagon Capital Advisors as of June 30, 2022
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 20 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 31.2 | $117M | 2.6M | 45.22 | |
| Arcus Biosciences Incorporated (RCUS) | 18.1 | $68M | 2.7M | 25.34 | |
| Chinook Therapeutics | 11.9 | $45M | 2.6M | 17.49 | |
| Horizon Therapeutics Pub L SHS | 7.0 | $26M | 330k | 79.76 | |
| Gossamer Bio (GOSS) | 6.2 | $23M | 2.8M | 8.37 | |
| Celldex Therapeutics Com New (CLDX) | 5.5 | $21M | 761k | 26.96 | |
| Spdr Ser Tr S&p Biotech (XBI) | 4.8 | $18M | 243k | 74.27 | |
| Stoke Therapeutics (STOK) | 2.7 | $10M | 764k | 13.21 | |
| Bridgebio Pharma (BBIO) | 2.3 | $8.5M | 934k | 9.08 | |
| Vera Therapeutics Cl A (VERA) | 2.1 | $7.8M | 575k | 13.61 | |
| Arvinas Ord (ARVN) | 2.0 | $7.5M | 179k | 42.09 | |
| Avidity Biosciences Ord (RNA) | 1.2 | $4.7M | 322k | 14.53 | |
| 4d Molecular Therapeutics In (FDMT) | 1.2 | $4.4M | 633k | 6.98 | |
| Keros Therapeutics (KROS) | 1.1 | $4.2M | 152k | 27.63 | |
| I Mab Sponsored Ads (IMAB) | 0.6 | $2.3M | 200k | 11.30 | |
| Prometheus Biosciences | 0.6 | $2.3M | 80k | 28.23 | |
| Immunovant (IMVT) | 0.6 | $2.3M | 579k | 3.90 | |
| Century Therapeutics (IPSC) | 0.6 | $2.2M | 260k | 8.40 | |
| Mereo Biopharma Group Ads (MREO) | 0.3 | $1.1M | 1.0M | 1.12 | |
| Ambrx Biopharma Sponsored Ads | 0.1 | $325k | 123k | 2.65 |
